Lv1
60 积分 2023-10-16 加入
The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy
10天前
已完结
Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward
10天前
已完结
Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy
10天前
已完结
Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti‐PLA2R positive primary membranous nephropathy
14天前
已完结
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
18天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
25天前
已完结
A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts
1个月前
已完结
Cloning, Expression, and Purification of Monoclonal Antibodies in scFv-Fc Format
2个月前
已完结
Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment
2个月前
已完结
An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies
2个月前
已完结
皖公网安备34019202002308
